Biotricity issues 8.95M common shares on conversion of Series A Preferred

BIOTRICITY INC.

Issued 8,952,172 common shares to investors upon conversion of 6,104 Series A Preferred shares plus accrued dividends and fees.
Shares were issued on June 4, 2024 under Section 4(a)(2) exemption; not registered with SEC.
The filing was made on June 7, 2024, reporting the unregistered sale of equity securities.
Conversion of preferred stock dilutes existing common shareholders by adding 8.95M shares to outstanding count.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.